ATE93136T1 - Pharmazeutische zubereitung zur oralen verabreichung in fluessiger form. - Google Patents

Pharmazeutische zubereitung zur oralen verabreichung in fluessiger form.

Info

Publication number: ATE93136T1
Authority: AT; Austria
Prior art keywords: oral administration; liquid form; pharmaceutical preparation; psychotropic; granules
Prior art date: 1989-12-30

Application number

AT90203430T

Other languages

English (en)

Inventor

Gerrit Bernardus Maria Beuving

Nijs Henrik De

Original Assignee

Akzo Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-30

Filing date

1990-12-19

Publication date

1993-09-15

1990-12-19 Application filed by Akzo Nv filed Critical Akzo Nv

1993-09-15 Application granted granted Critical

1993-09-15 Publication of ATE93136T1 publication Critical patent/ATE93136T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT90203430T 1989-12-30 1990-12-19 Pharmazeutische zubereitung zur oralen verabreichung in fluessiger form. ATE93136T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
NL8903199		1989-12-30

Publications (1)

Publication Number	Publication Date
ATE93136T1 true ATE93136T1 (de)	1993-09-15

Family

ID=19855853

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90203430T ATE93136T1 (de)	1989-12-30	1990-12-19	Pharmazeutische zubereitung zur oralen verabreichung in fluessiger form.

Country Status (14)

Country	Link
US (1)	US5238688A (de)
EP (1)	EP0436252B1 (de)
JP (1)	JP3051459B2 (de)
KR (1)	KR0156735B1 (de)
AT (1)	ATE93136T1 (de)
AU (1)	AU634614B2 (de)
CA (1)	CA2033418C (de)
DE (1)	DE69002822T2 (de)
DK (1)	DK0436252T3 (de)
ES (1)	ES2060001T3 (de)
IE (1)	IE63986B1 (de)
NZ (1)	NZ236626A (de)
PT (1)	PT96401B (de)
ZA (1)	ZA9010452B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5328688A (en) *	1990-09-10	1994-07-12	Arch Development Corporation	Recombinant herpes simplex viruses vaccines and methods
ES2212550T3 (es) *	1998-04-02	2004-07-16	Akzo Nobel N.V.	Solucion oral liquida que comprende el antidepresor mirtazapina.
US6492320B2 (en) *	1999-09-24	2002-12-10	Rohm And Hass Company	Multifunctional, granulated pellet aid and process
TWI256309B (en) *	1999-10-13	2006-06-11	Akzo Nobel Nv	New formulation of mirtazapine
NZ534746A (en) *	2002-03-12	2006-06-30	Bristol Myers Squibb Co	Palatable oral suspension and method
US7632521B2 (en) *	2003-07-15	2009-12-15	Eurand, Inc.	Controlled release potassium chloride tablets
US7838029B1 (en) *	2003-07-31	2010-11-23	Watson Laboratories, Inc.	Mirtazapine solid dosage forms
US20070298107A1 (en) *	2003-11-25	2007-12-27	Aurobindo Pharma Ltd.	Pharmaceutical Compositions of Mirtazapine
DE102004034043A1 (de) *	2004-07-13	2006-02-09	Krka Tovarna Zdravil, D.D.	Feste pharmazeutische Zusammensetzung, die Mirtazapin enthält
US7811604B1 (en)	2005-11-14	2010-10-12	Barr Laboratories, Inc.	Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4128641A (en) *	1975-07-31	1978-12-05	Hzi Research Center Inc.	Tetracyclic psychotropic drug
NL7809726A (nl) *	1978-09-26	1980-03-28	Akzo Nv	Nieuwe tetracyclische verbindingen.
JPS5665825A (en) *	1979-10-31	1981-06-03	Mochida Pharmaceut Co Ltd	Remedy for peptic ulcer
US4623588A (en) *	1984-02-06	1986-11-18	Biotek, Inc.	Controlled release composite core coated microparticles
US4870060A (en) *	1985-03-15	1989-09-26	Janssen Pharmaceutica	Derivatives of γ-cylodextrin
DE3612212A1 (de) *	1986-04-11	1987-10-15	Basf Ag	Verfahren zur herstellung von festen pharmazeutischen formen
GB8613688D0 (en) *	1986-06-05	1986-07-09	Euro Celtique Sa	Pharmaceutical composition
ES2038669T3 (es) *	1986-09-18	1993-08-01	London School Of Pharmacy Innovations Ltd	Formulacion farmaceutica.
ES2194832T3 (es) *	1987-10-16	2003-12-01	Elan Corp Plc	Formulaciones de ditiazem con absorcion controlada.
EP0319061A1 (de) *	1987-11-28	1989-06-07	Akzo N.V.	Antiemetisches Arzneimittel

1990
- 1990-12-14 IE IE453190A patent/IE63986B1/en not_active IP Right Cessation
- 1990-12-19 DE DE90203430T patent/DE69002822T2/de not_active Expired - Fee Related
- 1990-12-19 DK DK90203430.5T patent/DK0436252T3/da active
- 1990-12-19 ES ES90203430T patent/ES2060001T3/es not_active Expired - Lifetime
- 1990-12-19 EP EP90203430A patent/EP0436252B1/de not_active Expired - Lifetime
- 1990-12-19 AT AT90203430T patent/ATE93136T1/de not_active IP Right Cessation
- 1990-12-21 AU AU68398/90A patent/AU634614B2/en not_active Ceased
- 1990-12-21 NZ NZ236626A patent/NZ236626A/xx unknown
- 1990-12-27 JP JP2418600A patent/JP3051459B2/ja not_active Expired - Fee Related
- 1990-12-27 US US07/634,832 patent/US5238688A/en not_active Expired - Lifetime
- 1990-12-28 PT PT96401A patent/PT96401B/pt not_active IP Right Cessation
- 1990-12-28 ZA ZA9010452A patent/ZA9010452B/xx unknown
- 1990-12-28 CA CA002033418A patent/CA2033418C/en not_active Expired - Fee Related
- 1990-12-29 KR KR1019900022344A patent/KR0156735B1/ko not_active IP Right Cessation

Also Published As

Publication number	Publication date
NZ236626A (en)	1992-10-28
AU6839890A (en)	1991-07-04
AU634614B2 (en)	1993-02-25
ES2060001T3 (es)	1994-11-16
IE904531A1 (en)	1991-07-03
US5238688A (en)	1993-08-24
CA2033418C (en)	2002-05-14
KR0156735B1 (ko)	1998-11-16
EP0436252B1 (de)	1993-08-18
JP3051459B2 (ja)	2000-06-12
PT96401A (pt)	1991-10-15
JPH04210638A (ja)	1992-07-31
IE63986B1 (en)	1995-06-28
KR910011266A (ko)	1991-08-07
CA2033418A1 (en)	1991-07-01
EP0436252A1 (de)	1991-07-10
ZA9010452B (en)	1991-10-30
DK0436252T3 (da)	1993-12-27
DE69002822T2 (de)	1993-12-23
PT96401B (pt)	1998-06-30
DE69002822D1 (de)	1993-09-23

Similar Documents

Publication	Publication Date	Title
DE69330672D1 (de)	2001-10-04	Pharmazeutische zubereitung zur anwendung in den atemwegen
ATE164080T1 (de)	1998-04-15	Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole
IL80149A (en)	1990-11-29	Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
DE69425932D1 (de)	2000-10-26	Schnellauflösliche pharmazeutische Dosierungsformen und Verfahren zu ihrer Herstellung
IT1231434B (it)	1991-12-04	Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
EP0552256A4 (de)	1994-04-27
DE69519685D1 (de)	2001-01-25	Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
ATE93136T1 (de)	1993-09-15	Pharmazeutische zubereitung zur oralen verabreichung in fluessiger form.
EP0357793A4 (en)	1991-06-05	Suspended-release preparation prepared by using alginic acid
PT615754E (pt)	2002-11-29	Formas solidas de administracao oral de libertacao controlada flupertina
ATE138590T1 (de)	1996-06-15	Pyrogensorbentmittel
MC2025A1 (fr)	1990-04-25	Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
IL95444A0 (en)	1991-06-30	(quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents,their preparation and pharmaceutical compositions containing them
ATE38151T1 (de)	1988-11-15	Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
DE59009378D1 (de)	1995-08-10	Diclofenac-Natrium enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung.
DE3771260D1 (de)	1991-08-14	Kalziumkarbonatsuspension enthaltende pharmazeutische zusammensetzung.
DE69017839D1 (de)	1995-04-20	NMDA-blockierende Verbindungen, pharmazeutische Präparate, deren Herstellung und Verwendung.
DE3773716D1 (de)	1991-11-21	Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.
DE69003466D1 (de)	1993-10-28	Substituierte Thienopyrimidin-Derivate, deren Herstellung, pharmazeutische Zusammensetzungen und medizinische Verwendung.
LV10917A (lv)	1995-12-20	Bambuterina pielietojums lipidu saturu pazeminosu farmaceitisku kompoziciju pagatavosanai
SE8106498L (sv)	1983-05-04	Kvaternera salter av n,n3-di(beta-brompropionyl)-n1,n2-dispirotripiperazinium, forfarande for framstellning av desamma och lekemedelspreparat innehallande desamma
DE69416034D1 (de)	1999-03-04	Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen
DE68900574D1 (de)	1992-01-30	Pharmazeutische zusammensetzung.
DE3683550D1 (de)	1992-03-05	Verwendung eines quinazolinons zur herstellung eines arzneimittels gegen vertigo und pharmazeutische zusammensetzung.
IT8819541A0 (it)	1988-02-25	Composizione farmaceutica per somministrazione nasale.

Legal Events

Date	Code	Title	Description
1994-04-15	UEP	Publication of translation of european patent specification
2007-09-15	REN	Ceased due to non-payment of the annual fee